Form 4: Director Hodgson Receives ALHC Restricted Stock Units

Alignment Healthcare Director David C. Hodgson was granted 18,982 restricted stock units, vesting in one year, with receipt deferred.

Summary

• David C. Hodgson, a Director of Alignment Healthcare, Inc. (ALHC), was granted 18,982 restricted stock units (RSUs) on March 13, 2026.
• Each restricted stock unit represents the right to receive one share of ALHC Common Stock.
• The RSUs will vest on March 13, 2027, which is the one-year anniversary of the grant date, provided Mr. Hodgson continues to serve as a member of the Board of Directors.
• Mr. Hodgson has elected to defer the receipt of the underlying shares until his separation from service as a director or, if earlier, until a change of control of the company.
• The restricted stock units granted to Mr. Hodgson are held by him solely for the benefit of General Atlantic Service Company, L.P., and he disclaims beneficial ownership of these units and the underlying Common Stock.
• Following this transaction, Mr. Hodgson beneficially owns 173,408 shares of Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine director compensation and alignment of interests, without indicating any significant operational or financial changes for the company.

Positives

• The grant of 18,982 restricted stock units to Director David C. Hodgson aligns his interests with long-term shareholder value.
• The one-year vesting schedule encourages continued service on the Board of Directors, promoting stability in governance.

Future Outlook

The deferral of restricted stock unit receipt until separation of service or a change of control indicates a long-term perspective for the director's equity holdings and continued alignment with the company's future performance.

Industry Context

StockSavvy.ai notes that restricted stock unit grants are a common and effective form of equity compensation for non-employee directors across various industries, including healthcare technology. This practice is standard for public companies like Alignment Healthcare, as it helps align the interests of directors with the long-term value creation for shareholders.

Comparison to Industry Standards

• The grant of restricted stock units to directors is a standard compensation practice across various industries, including healthcare, for public companies.
• Companies such as Humana (HUM) and Centene (CNC) also utilize equity awards, often in the form of RSUs, to compensate their non-employee directors, typically with vesting periods tied to continued service.
• The $0 price for the acquisition of these restricted stock units is typical for such grants, representing compensation rather than a purchase.

Related Party Transactions

• The restricted stock units are held by Mr. Hodgson solely for the benefit of General Atlantic Service Company, L.P., which may indicate a relationship between the director and this entity regarding the beneficial ownership of these securities.

Stakeholder Impact

• Shareholders: The grant of equity compensation to a director further aligns their interests with the long-term performance and value creation for shareholders.
• Management: Reinforces stability within the board leadership by incentivizing continued service.

Next Steps

• David C. Hodgson's continued service as a Director of Alignment Healthcare, Inc.
• Vesting of the 18,982 restricted stock units on March 13, 2027, contingent on continued service.
• Receipt of the underlying shares upon Mr. Hodgson's separation of service as a director or a change of control of the Company.

Key Dates

Recommendation

This Form 4 filing details a routine grant of restricted stock units to a director as part of their compensation package. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It primarily indicates ongoing director compensation and alignment of interests, suggesting a 'hold' recommendation as there are no new catalysts for significant price movement based on this filing alone.

Keywords

Alignment Healthcare, ALHC, Form 4, insider transaction, restricted stock units, RSU, director compensation, David C. Hodgson, General Atlantic